Day

December 8, 2017
Issue 24 of Multiple Myeloma Research Review.   Highlights include: Is MRD the best predictor of response? ctDNA and risk of distant relapse. Cardiac safety of bortezomib. Cytogenic evolution in relapsed MM. Download here
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand